As of 2026-08-25, Silexion Therapeutics Corp Ordinary Shares (SLXN) has a 3-month relative strength percentile of 1 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 20. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 14.9%, relative volume 0.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SLXN is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -81.7% / -97.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SLXN Jan avg: -5.08% median: -5.08% win: 0% σ: 0.56% n: 2 2024-08-19 → 2026-07-31 | SLXN Feb avg: -24.71% median: -24.71% win: 0% σ: 26.83% n: 2 2024-08-19 → 2026-07-31 | SLXN Mar avg: -11.50% median: -11.50% win: 50% σ: 20.22% n: 2 2024-08-19 → 2026-07-31 | SLXN Apr avg: -31.33% median: -31.33% win: 0% σ: 29.49% n: 2 2024-08-19 → 2026-07-31 | SLXN May avg: -7.09% median: -7.09% win: 50% σ: 17.96% n: 2 2024-08-19 → 2026-07-31 | SLXN Jun avg: -35.09% median: -35.09% win: 0% σ: 18.35% n: 2 2024-08-19 → 2026-07-31 | SLXN Jul avg: -1.66% median: -1.66% win: 50% σ: 34.82% n: 2 2024-08-19 → 2026-07-31 | SLXN Aug avg: -38.07% median: -38.07% win: 0% σ: 18.30% n: 2 2024-08-19 → 2026-07-31 (current) | SLXN Sep avg: -58.79% median: -58.79% win: 0% σ: 7.41% n: 2 2024-08-19 → 2026-07-31 | SLXN Oct avg: -23.18% median: -23.18% win: 0% σ: 29.20% n: 2 2024-08-19 → 2026-07-31 | SLXN Nov avg: -4.76% median: -4.76% win: 50% σ: 13.92% n: 2 2024-08-19 → 2026-07-31 | SLXN Dec avg: -30.06% median: -30.06% win: 0% σ: 2.97% n: 2 2024-08-19 → 2026-07-31 |